Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective
- 27 December 1999
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 21 (6), 1249-1273
- https://doi.org/10.1016/s0731-7085(99)00244-7
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applicationsJournal of Biopharmaceutical Statistics, 1998
- Pharmacokinetic Studies with Recombinant CytokinesClinical Pharmacokinetics, 1997
- Demonstration of a Leptin Binding Factor in Human SerumBiochemical and Biophysical Research Communications, 1997
- Measurement and Analysis of Unbound Drug ConcentrationsClinical Pharmacokinetics, 1996
- A strategy for validation of bioanalytical methodsJournal of Pharmaceutical and Biomedical Analysis, 1996
- An analysis of the Washington Conference Report on bioanalytical method validationJournal of Pharmaceutical and Biomedical Analysis, 1994
- Interaction of Tacrolimus (FK506) and Its Metabolites with FKBP and CalcineurinBiochemical and Biophysical Research Communications, 1994
- The Role of Pharmacokinetics in the Development of Biotechnologically Derived AgentsClinical Pharmacokinetics, 1992
- Calibration and validation of linearity in chromatographic biopharmaceutical analysisJournal of Pharmaceutical and Biomedical Analysis, 1991
- Method validation in the bioanalytical laboratoryJournal of Pharmaceutical and Biomedical Analysis, 1990